WEB SEARCH


TOP SELECTION

CONTACT US

info_demofinance@mynasdaq.it

DONATION

All profits of this web site are donated to charity 'the arsenal of peace'. VISIT THE WEBSITE

ADS

Complete financial analysis of CEPHALON INC (CEPH)

Name CEPHALON INC
Year low N/A
Year High N/A
Symbol CEPH
Last trade 0.00
Percentage change N/A
Volume
Media Volume (3m) 0
PE Ratio N/A
EPS N/A
Market Cap
Media fatt 0
Trend fatt trend fatt graph for CEPHALON INC
Media net income 0
Trend net income trend net income for CEPHALON INC
P / E P / E graph for CEPHALON INC - 0 points 0
EPS EPS graph for CEPHALON INC - 5 points 5
MARKET CAP / TOTAL REVENUE market cap / total revenue graph for CEPHALON INC - points
TOT REV 1 / TOT REV 2 TOT REV 1 / TOT REV 2 graph for CEPHALON INC - points
NET INC 1 / NET INC 2 NET INC 1 / NET INC 2 graph for CEPHALON INC - 12 points 12
MED NET INC / MED TOT REV MED NET INC / MED TOT REV graph for CEPHALON INC - points
NET INCOME / MARKET CAP NET INCOME / MARKET CAP graph for CEPHALON INC - points
TOTALREV1/TOTALREV3 totalRev1/totalRev3 graph for CEPHALON INC - points
NET INC1/NET INC3 net inc1/net inc3 graph for CEPHALON INC - 10 points 10
TOT REV 2/ TOT REV 3 tot rev 2/ tot rev 3 graph for CEPHALON INC - points
NET INC 2 / NET INC 3 net inc 2 / net inc 3 graph for CEPHALON INC - 10 points 10
. . graph for CEPHALON INC - points
MARKET CAP / NET TANGIBLE ASSETS MARKET CAP / NET TANGIBLE ASSETS graph for CEPHALON INC - points
MARK CAP/TOT STOCK EQ MARK CAP/TOT STOCK EQ graph for CEPHALON INC - points
MARKET CAP / TOT CURRENT ASSETS market cap / tot current assets graph for CEPHALON INC - points
TOT CURR ASSETS / TOT LIAB TOT CURR ASSETS / TOT LIAB graph for CEPHALON INC - points
. . graph for CEPHALON INC - points
SELL HOLD BUY SELL HOLD BUY graph for CEPHALON INC - 0 points 0
SINTESE 37

GRAPHS

max price logarithm graph for CEPHALON INC based on no conditions max volume linear graph for CEPHALON INC based on no conditions

News

S&P Indices Announces Change to U.S. Index (Oct 12 - reuters) » More CEPH.DF Market Views (Oct 10 - reuters) UPDATE 1-Cephalon gets subpoena from U.S. DOJ (Oct 07 - reuters) EU mergers and takeovers (Sept 23) (Oct 07 - reuters) Teva offers EU watchdog concessions for Cephalon buy (Oct 07 - reuters) Cephalon sues Sandoz over Fentora cancer drug (Oct 07 - reuters) EU mergers and takeovers (Aug 29) (Oct 07 - reuters) Dealtalk: Traders take a hit as M&A deals totter (Oct 07 - reuters) DEALTALK-Traders take a hit as M&A deals totter (Oct 07 - reuters) Valeant has talked takeover with Medicis: report (Oct 07 - reuters) Valeant has talked takeover with Medicis-WSJ (Oct 07 - reuters) 5 Biotech Stocks Seeing Significant Short Covering (Oct 03 - reuters) Teva: Growth, Yield And Value All Wrapped In One Package (Oct 02 - reuters) Why the Future Looks Bright for Endo Pharmaceuticals (Sep 29 - reuters) Russian gangs behind global medicine scams - UK police (Sep 29 - reuters) 5 Highly Shorted Healthcare Stocks Being Sold By Smart Money (Sep 27 - reuters) REFILE-UPDATE 1-Valeant offers C$88 mln for Afexa, tops Paladin (Sep 26 - reuters) Valeant to offer C$88 mln for Afexa, tops Paladin (Sep 26 - reuters) Teva offers EU watchdog concessions for Cephalon buy (Sep 23 - reuters) EU mergers and takeovers (Sept 23) (Sep 23 - reuters) EU mergers and takeovers (Sept 22) (Sep 22 - reuters) EU mergers and takeovers (Sept 14) (Sep 14 - reuters) EU mergers and takeovers (Sept 12) (Sep 12 - reuters) Here's 1 Reason Endo Pharmaceuticals Looks Weak (Aug 26 - reuters) Cephalon Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00% Convertible Senior Subordinated Notes due 2015 (Aug 22 - reuters) Why the Street Should Expect Big Things from Hospira (Aug 08 - reuters) UPDATE 3-Generic threat to Valeant drug send shares reeling (Aug 04 - reuters) 1 Reason Hospira's Earnings Aren't So Hot (Aug 04 - reuters) Cephalon Reported Financial Results for the Second Quarter of 2011 (Aug 03 - reuters) STOCKS NEWS EUROPE-BNP Paribas, Barclays eyed on Tuesday (Aug 01 - reuters) The Tale of 2 Generic-Drug Makers (Jul 30 - reuters) Valeant makes approach for drugmaker Meda: report (Jul 27 - reuters) Cephalon Receives FDA Approval for Risk Evaluation and Mitigation Strategy for FENTORA and ACTIQ (Jul 21 - reuters) » More CEPH.O Market Views (Jul 15 - reuters) Cephalon Shareholders Approve Acquisition by Teva (Jul 14 - reuters) Feds Probe Cephalon for Off-Label Treanda Promotion: Implications for Teva Are Unclear (Jul 13 - reuters) RPT-UPDATE 1-Mesoblast's late-stage stem cell trial gets FDA nod (Jul 08 - reuters) Why the Street Should Love Endo Pharmaceuticals' Earnings (Jul 07 - reuters) Cephalon to Release Second Quarter 2011 Earnings Results After the Market Close on August 2, 2011 (Jun 29 - reuters) Faruqi & Faruqi, LLP Announces Investigation of Cephalon, Inc. (Jun 25 - reuters) Faruqi & Faruqi, LLP Announces Investigation of Cephalon, Inc. (Jun 25 - businesswire) 5 Healthcare Companies Trading Under 10 Times FCF (Jun 16 - reuters) U.S. stock index futures signal early bounce (Jun 14 - reuters) Stock index futures signal early bounce (Jun 14 - reuters) Athersys Releases Impressive 12 Month Heart Attack Data for MultiStem (Jun 10 - reuters) Bullish On Aastrom (Jun 03 - reuters) Valeant Buys Sanitas to Broaden Generics (May 24 - reuters) Cephalon Granted Temporary Restraining Order in AMRIX® Patent Litigation (May 20 - reuters) Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Cephalon, Inc. (May 19 - businesswire) Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Cephalon, Inc. (May 19 - reuters)

ADS

MY PORTFOLIO



GAIN vs LOSS


BEST vs WORST


SELECTION DIY

Market Cap
Last Trade
Gain/Loss
Webtech:
P / E
EPS
market cap / total revenue
TOT REV 1 / TOT REV 2
NET INC 1 / NET INC 2
MED NET INC / MED TOT REV
NET INCOME / MARKET CAP
totalRev1/totalRev3
net inc1/net inc3
tot rev 2/ tot rev 3
net inc 2 / net inc 3
.
MARKET CAP / NET TANGIBLE ASSETS
MARK CAP/TOT STOCK EQ
market cap / tot current assets
TOT CURR ASSETS / TOT LIAB
.
SELL HOLD BUY